SWX:GALEHealthcare
A Look At Galenica (SWX:GALE) Valuation After 2025 Sales Growth And Earnings Guidance Update
Galenica (SWX:GALE) has drawn fresh attention after reporting 2025 group sales of CHF 4,135.6 million, reaffirming dividend guidance, and confirming EBIT is expected to rise 10 to 12% following the Labor Team acquisition.
See our latest analysis for Galenica.
Those full year sales and earnings updates have arrived alongside a CHF97.25 share price, with a 15.16% 90 day share price return and a 23.46% 1 year total shareholder return suggesting momentum has strengthened recently.
If you are...